[2P-343] CyclosporinA derivative as therapeutic candidate for Alport syndrome by inducing mutant type IV collagen secretion

^○Mary Ann Suico^1,2, Jun Kuwazuru¹, Kohei Omachi¹, Haruka Kojima¹, Misato Kamura¹, Shota Kaseda¹, Yuya Sannomiya¹, Jun Horizono¹, Yuimi Koyama¹, Aimi Owaki¹, Tsuyoshi Shuto^1,2, Hirofumi Kai^1,2 (1.Dept. of Mol. Med., Grad. Sch. of Pharm. Sci., Kumamoto Univ., 2.Global Ctr. for Nat. Resources Sci., Facul. of Life Sci., Kumamoto Univ.)